US EditionAPLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit
- Purchasers of Applied Therapeutics, Inc. securities from January 3, 2024, to December 2, 2024, must act by February 18, 2025, to lead a class-action lawsuit, as highlighted by the Rosen Law Firm.
- A class action lawsuit has been filed alleging that Applied Therapeutics concealed important clinical trial details, misleading investors regarding protocol adherence and the risk of FDA rejection.
- The Rosen Law Firm states that affected investors may obtain compensation without upfront costs through a contingency fee arrangement.
- The lawsuit contends that improper adherence to trial protocols posed significant risks of FDA rejection, causing investor damages when the truth emerged.
Insights by Ground AI
Does this summary seem wrong?
19 Articles
19 Articles
All
Left
2
Center
7
Right
INVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, Feb. 17, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the "Class…
·Georgia, United States
Read Full ArticleCoverage Details
Total News Sources19
Leaning Left2Leaning Right0Center7Last UpdatedBias Distribution78% Center
Bias Distribution
- 78% of the sources are Center
78% Center
L 22%
C 78%
Factuality
To view factuality data please Upgrade to Premium
